Dramatic response to inhaled dobesilate in a patient with lung squamous cell cancer.

about

Dramatic response to inhaled dobesilate in a patient with lung squamous cell cancer.

Item

http://www.wikidata.org/entity/Q35979621

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Dramatic response to inhaled dobesilate in a patient with lung squamous cell cancer.

@ast

Dramatic response to inhaled dobesilate in a patient with lung squamous cell cancer.

@en

type

Item

label

Dramatic response to inhaled dobesilate in a patient with lung squamous cell cancer.

@ast

Dramatic response to inhaled dobesilate in a patient with lung squamous cell cancer.

@en

prefLabel

Dramatic response to inhaled dobesilate in a patient with lung squamous cell cancer.

@ast

Dramatic response to inhaled dobesilate in a patient with lung squamous cell cancer.

@en

P1476

Dramatic response to inhaled dobesilate in a patient with lung squamous cell cancer.

@en

P2093

Antonio Sueiro

http://www.w3.org/2001/XMLSchema#string

Guillermo Giménez-Gallego

http://www.w3.org/2001/XMLSchema#string

Pedro Cuevas

http://www.w3.org/2001/XMLSchema#string

Pilar Navío

http://www.w3.org/2001/XMLSchema#string

P2860

Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors

Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells

Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonate

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.

Erlotinib in previously treated non-small-cell lung cancer

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition.

Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model

The expanding role of vascular endothelial growth factor inhibitors in ophthalmology.

P31

scholarly article

case report

P356

10.1136/BCR-2012-006622

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22952275

http://www.w3.org/2001/XMLSchema#string

P932

4544079

http://www.w3.org/2001/XMLSchema#string